Alvotech (ALVO) Change in Account Payables (2021 - 2026)
Alvotech's (ALVO) quarterly Change in Account Payables came in at $30.7 million in Q2 2026, up 120.08% on a YoY basis from $13.9 million in Q2 2025, and up 189.4% quarter-over-quarter from -$34.3 million in Q1 2026.
Analysis
Alvotech (ALVO) Change in Account Payables (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Change in Account Payables for 6 consecutive years, with $30.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Account Payables rose 120.08% year-over-year to $30.7 million; the trailing twelve-month figure through Jun 2026 stood at $23.9 million (up 1229.66% YoY), and the FY2025 full-year result was $45.3 million, up 430.87% from the prior year.
- Change in Account Payables rose to $30.7 million in Q2 2026 per ALVO's latest filing, from -$34.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $73.2 million in Q4 2025 and bottomed at -$45.7 million in Q3 2025.
- Historically, Change in Account Payables has averaged $4.3 million across 5 years, with a median of $6.9 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables jumped 634.86% in 2025, then plunged 1001.76% in 2026.
- Over 5 years, Change in Account Payables stood at $6.6 million in 2022, then surged by 393.11% to $32.3 million in 2023, then plunged by 142.35% to -$13.7 million in 2024, then surged by 634.86% to $73.2 million in 2025, then plunged by 58.09% to $30.7 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $30.7 million, -$34.3 million, and $73.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -21.20 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 45.25 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -8.53 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 30.70 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -1.12 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.70 Mn |
| Mar 31, 2026 | -34.34 Mn |
| Dec 31, 2025 | 73.25 Mn |
| Sep 30, 2025 | -45.69 Mn |
| Jun 30, 2025 | 13.95 Mn |
| Mar 31, 2025 | 3.81 Mn |
| Dec 31, 2024 | -13.70 Mn |
| Sep 30, 2024 | -6.18 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Mar 31, 2024 | -28.93 Mn |
| Dec 31, 2023 | 32.34 Mn |
| Jun 30, 2023 | 12.42 Mn |
| Dec 31, 2022 | 6.56 Mn |
| Jun 30, 2022 | 8.87 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 3.72 Mn |